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The complete amino acid sequence of the nucleic acid-binding protein p12 of bovine leukemia virus (BLV) 
has been determined. Peptides were generated by enzymatic digestion and formic acid cleavage, purified 
by reversed-phase liquid chromatography and subjected to automated Edman degradation. BLV p12 is a 
proline-rich linear polypeptide composed of 69 amino acids with IW 7558. A comparison of the p12 
structure to that of the avian and murine type C retroviral nucleic acid-binding proteins hows ignificant 
homology only in the putative binding domain. This conserved region is duplicated in BLV p12 as in the 
avian homolog. 
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1. INTRODUCTION 
Bovine leukemia virus (BLV) is an exogenous 
non-genetically transmitted retrovirus shown to be 
associated with enzootic bovine leukosis or lym- 
phosarcoma [ 1,2]. BLV is immunologically 
distinct from other retroviruses and has not been 
readily classified into any of the well-defined 
groups [3]. Previously we found [4] that the major 
core protein p24 of BLV has amino acid sequence 
homology to type C virus major core proteins ~30s 
especially to that of feline leukemia virus (FeLV), 
another naturally occurring infectious retrovirus. 
The extent of the structural homology of the major 
internal virion proteins suggested that BLV and 
FeLV may have originated from a common pro- 
genitor [4]. Substantial amino acid sequence data 
for the various structural proteins of a large 
number of retroviruses has been accumulated from 
studies conducted primarily in this laboratory [5]. 
To obtain further insight into the relationship bet- 
ween BLV and type C viruses of other species, ex- 
tensive primary structure analyses of BLV gag gene 
products were undertaken. BLV ~12, a low-M, 
basic protein [6,7], has also been shown to bind to 
single-stranded nucleic acids [6]. Here, we report 
the complete amino acid sequence of BLV ~12. 
2. MATERIALS AND METHODS 
2.1. Virus 
BLV grown in fetal lamb kidney cells [8,9] was 
purified by conventional sucrose density gradient 
centrifugation and obtained from the Biological 
Products Laboratory of the NCI-Frederick Cancer 
Research Facility (Frederick MD). 
2.2. Protein purification 
BLV p12 was purified by neutral chloroform 
methanol extraction of aqueous virus suspensions 
[lo] followed by reversed phase liquid 
chromatography (RPLC) as in [ 111. 
2.3. Protein carboxamidomethylation 
Prior to fragmentation, p12 was reduced with 
dithiothreitol and carboxamidomethylated (with 
iodoacetamide) as in [12]. To remove excess 
reagents and side products, the pH of the reaction 
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mixture was lowered to about 2 with aqueous 
trifluoroacetic acid (TFA) before Ioading it onto a 
Waters Cur RPLC column. The modified protein 
was readily obtained by elution with linear 
acetonitrile gradient (O-30%) containing 0.05qo 
TFA. Protein eluted at about 26% acetonitrile. 
2.4. Digestion with Lys-C protease 
Thirty nmol of ~~~~~dornethyl p12 was 
dissolved in 0.5 ml 0.1 M sodium bicarbonate 
@H 8.5) containing 20% acetonitrile [13]. Lys-C 
protease (Boehringer-Mannheim Biochemicals, 
Indianapolis IN) was added and allowed to react at 
an enzyme to substrate ratio of 1:75 under 
nitrogen for 24 h. 
2.5. Limited trypsin digestion 
The lysines in 25 nmol carboxamidomethyl p12 
were blocked with methyl-acetimidate as in [12] 
and the modified protein was digested with TPCK- 
trypsin (enzyme : protein = 1: 100) in 0.1 M sodium 
bicarbonate (pH 8.5) which was also 1 M 
guanidine hydrochloride. Reaction proceeded 
overnight at 37°C. 
2.6. Cleavage with formic acid 
Twenty nmol of c~box~idomethyl p12 was 
dissolved in 1 .O ml 70% formic acid 1141, heated at 
37°C overnight, diluted with water and 
lyophilized. 
2.7. Peptide puri~catio~ 
After the allotted time for enzymatic digestions, 
the pH of the solutions was lowered to pH 2 with 
aqueous TFA, either with or without he prior ad- 
dition of guanidine hydrochloride. Samples were 
loaded onto a Waters FBondapak Cl8 column. 
Peptides were eluted with a linear gradient of 
acetonitrile in water containing 0.05~0 
trifluoroacetic acid. Peaks were collected manually 
and aliquots taken for amino acid analysis. Amino 
acid analyses were carried out on a Durrum Model 
500 analyzer equipped with a PDP 8/A computing 
integrator. 
2.8. Sequence anaiysis of intact protein and 
peptides 
A Beckman sequenator updated to the level of a 
Model 890C and equipped with a cold trap was 
employed as in [15]. Peptides dissolved in aqueous 
38 
acetonitrile as obtained from RPLC purification 
were added directly to the spinning cup, dried and 
subjected to semi-automated E man degradation 
in the presence of Polybrene [ 161. PTH amino 
acids were analyzed on a phenylalkyl support 1171. 
2.9. Carboxyl-terminal analysis 
Four nmol of protein was digested with carbox- 
ypeptidase A as in [ 181, Amino acids reieased at 
timed intervals were determined by amino acid 
analysis. 
3. RESULTS AND DISCUSSION 
3.1. sequence determination 
The complete amino acid sequence of BLV p 12 
together with the sequence strategy employed is il- 
lustrated in fig.1. Amino-terminal analysis of in- 
tact unmodified protein was described in [ 111 in a 
report on the immunology of ~12. Peptides 
generated by Lys-C protease proved to be very 
useful. As illustrated in fig.1 these peptides were 
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Fig.1, The complete amino acid sequence of BLV p12 
and strategy for its determination. The structure shown 
was determined by semi-automated Edman degradation 
of intact protein and fragments derived by digestion with 
endoproteinase Lys-C (fragment designated with letter 
K) or trypsin (fragment designated with Ietter T) and by 
acid cleavage (fragment designated with letter A). The 
bars indicate the len8th (number of residues) of each 
peptide, while the shaded area indicates the extent to 
which sequence could be accurately determined. The 
letters under the bars indicate residues (single letter code, 
see legend to fig.2) which co&d not be unambiguously 
identified in the given peptide. 
Volume 156, number 1 FEBS LETTERS June 1983 
sequenced to the end. Peptides Kr-7 and K8-17 
were obtained by RPLC as a mixture and sequenc- 
ed together. Peptides &7-68 and K69 were located 
by amino acid analysis in the salt breakthrough 
peak of the RPLC separation. 
The NHz-terminal sequence determination of 
peptides Ts‘j-~j,, and ASS-69 provided the necessary 
overlap with Lys-C peptides in the COOH- 
terminal half of p12. Peptide Tfjl-69 was complete- 
ly sequenced and was found to be the COOH- 
terminal peptide of p12 as confirmed by the amino 
acid compositional data of intact protein and frag- 
ment, and also by COOH-terminal analysis of in- 
tact ~12. From the results of carboxypeptidase A
digestion the deduced sequence of p12 is -Lys- 
Asn-OH . 
3.2. Characterization f protein 
BLV p12 had the following composition (values 
calculated from the sequence are in parentheses): 
Asp 3.7(3), Asn(l), Thr 2.9(4), Ser 2.3(2), Glu 
2.1(l), Gin(l), Pro 14.8(18), Gly 5.8(6), Ala 3.1(3), 
Val 1.3(l), Met 0.7(l), Ile 1.0(l), Leu 2.0(2), Tyr 
0.8(l), His 2.2(3), Lys 7.4(8), Arg 4.8(5), Cys 
5.5(6) and Trp(2). Tryptophan was not determined 
on the analyzer. The values for the amino acids are 
in good agreement with those derived from the 
complete sequence shown in fig.1. 
BLV p12 is a linear polypeptide of 69 amino 
acids with a calculated M, of 7558. An assessment 
of the number and nature of the charged amino 
acid side chains and end groups indicate that BLV 
p12 is a highly basic protein in agreement with the 
previously noted high isoelectric point 161. It has 17 
basic groups (3 histidine, 8 lysine, 5 arginine and 
one a-amino group) and only 5 carboxyl groups (3 
aspartic acid, 1 glutamic acid and one a-carboxyl 
group). The number of proline residues is high: 18 
out of 69 total residues. Thus proline is occupying 
26% of the polypeptide chain. This high proline 
content is unusual among the retroviral nucleic 
acid-binding proteins analyzed. Twelve of the pro- 
lines appear in two internally homologous 
segments each comprising a total of 21 residues. 
The alignment of these internally duplicated 
regions is shown in fig.2. There are 14 amino acids 
out of 21 (66.7%) which are positionally identical 
(boxed). The most remarkable common feature of 
these repeated sequences is that they both contain 
the significant characteristic of the putative nucleic 
H-&IL” P10*,_4, LDRDQ@AYaKEKG@WAKDaPK 
f * * ..I. .I 
RSV P1212.62 :[::grg::$J:;;g[ 
Fig.2. Internal duplication of sequence in BLV p12 and 
ASV ~12. Alignment of fragments with the putative 
nucleic acid-binding domain of R-MuLV ~10. Internally 
repeated amino acids are boxed. The cysteines and 
histidine conserved inall fragments are circled. Asterisks 
indicate amino acids which occur at identical alignment 
positions in at least 2 of 3 species. The single letter code 
is that of Dayhoff [ZO]. 
acid-binding domain of retroviral nucleic acid- 
binding proteins expressed as a set of 3 cysteines 
(circled) [ 121 periodically placed at positions n, n + 
3 and n + 13. In addition to the 6 cysteines and 
most of the prolines, the other amino acids which 
appear positionally identical are glycine at residues 
22 and 47, histidine 32 and 57, tryptophan 33 and 
58, arginine 35 and 60, aspartic acid 36 and 61 and 
threonine 39 and 64. BLV p12 has been shown to 
bind to single-stranded DNA [6]. It remains to be 
determined whether both partially duplicated se- 
quences are functionally important in nucleic acid- 
binding. 
3.3. Sequence comparison with other retroviral 
nucleic acid binding proteins 
In the nucleic acid-binding proteins of murine 
leukemia viruses (MuLV) the putative nucleic acid- 
binding domain occurs only once [ 121. In the 
homologous structural protein p12 of avian sar- 
coma virus (ASV) this cysteine-containing region is 
duplicated as in BLV ~12. The data indicate that 
ASV p12 and BLV p 12 may have evolved by par- 
tial gene duplication. The alignments of the inter- 
nally repeated segments of BLV p12 and ASV p12 
[19] are shown together with the nucleic acid- 
binding domain of Rauscher (R)-MuLV p10 in 
fig.2. The cysteines and histidines (circled) are con- 
served in ah fragments. Other amino acids which 
appear positionally identical in at least 2 of the 3 
species are labeled with asterisks. 
39 
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In general, the results of comparison of amino 
acid sequences of the NBPs of type C retroviruses 
suggest hat the nucleic acid-binding regions are 
highly conserved. 
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